focus -WSS

focus

author：hotspot 2025-09-27 19:49:46 - browse：72798

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Republicans love RFK Jr. What's that tell us about health in 2024?

WSS

Trans patients at the end of life deserve respect and dignity

People can get long Covid without testing positive for virus: Study

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Former Pear Therapeutics executives start new VC firm

Abortion policy in the spotlight at Republican debate

Can U.S. cancer drug shortages be fixed?

focus

focus

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Trans patients at the end of life deserve respect and dignity

How one medical school became remarkably diverse

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

George Santos makes 1st court appearance after pleading not guilty to 13 counts

People can get long Covid without testing positive for virus: Study

The cancer drug shortage isn’t new — and neither are the solutions

National associations that represent hospice owe an apology

State Dept. review finds Biden bears some blame for Afghanistan failures

Vivek Ramaswamy made waves in the debate, much as in biotech

hotspot

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

PBMs are inflating the cost of generic drugs. They must be reined in

Adam's Biotech Scorecard: Do Sarepta's exon

Scientists successfully use ultrasound imaging to map brain activity

iTeos Therapeutics debuts first data on TIGIT

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

entertainment

focus

hotspot

hotspot